T1	Participants 403 489	462 patients with disseminated disease, 49 (10.6%) had CNS disease at diagnosis (CNS+)
T2	Participants 651 746	Of the CNS+ patients, 28 had M2 (5% to 25% blasts) or M3 (> 25% blasts) bone marrow involvement
